GoodRx Holdings, Inc. - Common Stock (GDRX)

Q3 2025 13F Holders as of 9/30/2025

Type / Class
Equity / Common Stock
Shares outstanding
98.7M
Number of holders
151
Total 13F shares, excl. options
117M
Shares change
-3.05M
Total reported value, excl. options
$496M
Value change
-$16.5M
Put/Call ratio
0.69
Number of buys
67
Number of sells
-107
Price
$4.23

Significant Holders of GoodRx Holdings, Inc. - Common Stock (GDRX) as of Q3 2025

212 filings reported holding GDRX - GoodRx Holdings, Inc. - Common Stock as of Q3 2025.
GoodRx Holdings, Inc. - Common Stock (GDRX) has 151 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 117M shares .
Largest 10 shareholders include Francisco Partners Management, LP (60.1M shares), VANGUARD GROUP INC (9.21M shares), AMERIPRISE FINANCIAL INC (3.89M shares), Silver Lake Group, L.L.C. (3.53M shares), RENAISSANCE TECHNOLOGIES LLC (3.47M shares), Petrus Trust Company, LTA (3.1M shares), DIMENSIONAL FUND ADVISORS LP (2.5M shares), LSV ASSET MANAGEMENT (2.35M shares), BlackRock, Inc. (1.97M shares), and Technology Crossover Management X, Ltd. (1.65M shares).
This table shows the top 151 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.